Atlas Trials

Envafolimab as First-line Treatment of Aged Patients in Advanced NSCLC

Clinical trial NCT05055167 · UNKNOWN

Trial details

NCT number
NCT05055167
Sponsor
The First Affiliated Hospital of Xiamen University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Non-small Cell Lung Cancer Stage IV
Start date
2021-08-30
Primary completion
2024-12-30
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.